Skip Navigation


NDT Advance Access originally published online on November 23, 2004
Nephrology Dialysis Transplantation 2005 20(1):105-113; doi:10.1093/ndt/gfh574
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
20/1/105    most recent
gfh574v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (14)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Szeto, C.-C.
Right arrow Articles by Lai, F. M.-M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Szeto, C.-C.
Right arrow Articles by Lai, F. M.-M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant Vol. 20 No. 1 © ERA-EDTA 2004; all rights reserved


Original Article

Messenger RNA expression of target genes in the urinary sediment of patients with chronic kidney diseases

Cheuk-Chun Szeto1, Rebecca Wing-Yan Chan1, Ka-Bik Lai1, Carol Yi-Ki Szeto1, Kai-Ming Chow1, Philip Kam-Tao Li1 and Fernand Mac-Moune Lai2

1 Department of Medicine and Therapeutics and 2 Department of Anatomical and Cellular Pathology, Prince of Wales Hospital, Chinese University of Hong Kong, Shatin, Hong Kong, China

Correspondence and offprint requests to: Dr C.C. Szeto, Department of Medicine & Therapeutics, Prince of Wales Hospital, Chinese University of Hong Kong, Shatin, NT, Hong Kong, China. Email: ccszeto{at}cuhk.edu.hk

Background. The degree of renal scarring in kidney biopsy is an important prognostic factor in patients with chronic kidney diseases. We hypothesize that gene expression in the urinary sediment reflects the degree of renal damage.

Methods. We studied 29 patients with chronic kidney disease who underwent kidney biopsy (12 immunoglobulin-A nephropathy and 17 glomerulosclerosis) and 10 healthy controls. The mRNA expressions of a panel of target genes in urinary sediment were measured by real-time quantitative polymerase chain reaction. The results were compared with the degree of histological damage and renal function decline.

Results. There were significant differences in the urinary expression of transforming growth factor-ß (TGF-ß), monocyte chemotactic protein-1 (MCP-1) and collagen IV between disease groups and controls. Urinary TGF-ß mRNA expression correlated significantly with estimated glomerular filtration rate (r = –0.412, P = 0.029) and the degree of tubulointerstitial scarring (r = 0.418, P = 0.024). Urinary MCP-1 expression correlated with the degree of glomerulosclerosis (r = 0.450, P = 0.014), but not tubulointerstitial scarring. Urinary MCP-1 expression correlated with its corresponding level by enzyme-linked immunosorbent assay (ELISA) (r = 0.650, P<0.001), but TGF-ß expression did not correlate with its ELISA level. Urinary TGF-ß gene expression correlated with its intra-renal expression in glomeruli (r = 0.701, P<0.001) and tubulointerstitium (r = 0.573, P = 0.001) by immunohistochemistry, while urinary MCP-1 gene expression correlated with its staining in glomeruli (r = 0.576, P = 0.001) but not tubulointerstitium. After 12 months, there was a significant inverse correlation between the rate of renal function decline and urinary expression of connective tissue growth factor (r = –0.471, P = 0.010) and collagen I (r = –0.399, P = 0.032), but not TGF-ß or MCP-1.

Conclusions. Amongst the target genes examined, the mRNA expression of TGF-ß in urinary sediment correlated with renal function, the degree of histological damage and intra-renal level in patients with chronic kidney diseases. Measurement of TGF-ß mRNA expression in urine may be a useful non-invasive tool for assessing the severity of renal damage in patients with chronic kidney diseases.

Keywords: monocyte chemotactic protein; renal failure; transforming growth factor


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Rheumatology (Oxford)Home page
G. Wang, F. M.-M. Lai, L.-S. Tam, E. K.-M. Li, B. C.-H. Kwan, K.-M. Chow, P. K.-T. Li, and C.-C. Szeto
Urinary FOXP3 mRNA in patients with lupus nephritis--relation with disease activity and treatment response
Rheumatology, July 1, 2009; 48(7): 755 - 760.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
G. Wang, F. M.-M. Lai, K.-B. Lai, K.-M. Chow, B. C.-H. Kwan, P. K.-T. Li, and C.-C. Szeto
Urinary messenger RNA expression of podocyte-associated molecules in patients with diabetic nephropathy treated by angiotensin-converting enzyme inhibitor and angiotensin receptor blocker
Eur. J. Endocrinol., March 1, 2008; 158(3): 317 - 322.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
G. Colucci, J. Floege, and F. P. Schena
The urinary sediment beyond light microscopical examination.
Nephrol. Dial. Transplant., June 1, 2006; 21(6): 1482 - 1485.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.